Open access · US-GOV via ClinicalTrials.gov Clinical trial

(MATE) Metformin and Aging Trial in the Elderly: A Pilot and Feasibility Study

Authors not listed

Mayo Clinic · 2018

Epigenetic alterations Metformin Human Randomized controlled trial

Abstract

This study will test whether chronic metformin administration will improve longevity of the cell, improves its machinery by reducing aging-related biochemical parameters and thereby improving physical performance, as measured by short physical performance battery test.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-07-02 MST

Cite this

APA

Anonymous. (2018). (MATE) Metformin and Aging Trial in the Elderly: A Pilot and Feasibility Study. <em>Mayo Clinic</em>. https://clinicaltrials.gov/study/NCT03451006

Vancouver

Anonymous. (MATE) Metformin and Aging Trial in the Elderly: A Pilot and Feasibility Study. Mayo Clinic. 2018.

BibTeX

@misc{anon2018MATEMe, title = {(MATE) Metformin and Aging Trial in the Elderly: A Pilot and Feasibility Study}, author = {Anonymous}, journal = {Mayo Clinic}, year = {2018}, }